Cargando…
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
The emergence of novel and evolving variants of SARS-CoV-2 has fostered the need for change in the form of newer and more adaptive diagnostic methods for the detection of SARS-CoV-2 infections. On the other hand, developing rapid and sensitive diagnostic technologies is now more challenging due to e...
Autores principales: | Fernandes, Queenie, Inchakalody, Varghese Philipose, Merhi, Maysaloun, Mestiri, Sarra, Taib, Nassiba, Moustafa Abo El-Ella, Dina, Bedhiafi, Takwa, Raza, Afsheen, Al-Zaidan, Lobna, Mohsen, Mona O., Yousuf Al-Nesf, Mariam Ali, Hssain, Ali Ait, Yassine, Hadi Mohamad, Bachmann, Martin F., Uddin, Shahab, Dermime, Said |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843115/ https://www.ncbi.nlm.nih.gov/pubmed/35132910 http://dx.doi.org/10.1080/07853890.2022.2031274 |
Ejemplares similares
-
Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer
por: Raza, Afsheen, et al.
Publicado: (2022) -
Role of Epstein–Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target
por: Fernandes, Queenie, et al.
Publicado: (2018) -
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
por: Taib, Nassiba, et al.
Publicado: (2023) -
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
por: Raza, Afsheen, et al.
Publicado: (2020) -
Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report
por: Merhi, Maysaloun, et al.
Publicado: (2020)